Related Experiment Video
Updated: Jun 23, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
c-Myc regulates the coordinated transcription of brain disease-related PDCD10-SERPINI1 bidirectional gene pair
Ping-Yen Chen1, Wun-Shaing W Chang, Yiu-Kay Lai
1National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan, ROC.
Abstract:
Two brain disease-related genes, one coding for the protease inhibitor SERPINI1 which is down-regulated in brain tumors, and the other for the PDCD10 programmed cell death gene which is often mutated in cerebral cavernous malformation, are closely adjacent in a head-to-head configuration and separated by only 851 bp on human chromosome 3q26. The 851-bp intergenic region contains a GC-rich 175-bp minimal bidirectional promoter which is essential for transcriptional activation of the two flanking genes. The oncogenic c-Myc transcription factor was identified to bind to a non-canonical E-box element (5'-CATGCG-3') of the minimal bidirectional promoter to drive both gene expressions. Methylation at the specific C nucleotide within the E-box sequence (5'-CATG(m)CG-3'), however, would severely interfere with the binding of c-Myc to the E-box. These results suggest that c-Myc plays an important role in regulating the coordinated transcription of the PDCD10-SERPINI1 bidirectional gene pair, and is possibly involved in differential expressions of these two neighboring genes in central nervous system diseases such as brain cancer.
Insights
The oncogenic c-Myc transcription factor regulates two brain disease genes, SERPINI1 and PDCD10. Its binding to a bidirectional promoter is affected by DNA methylation, impacting gene expression in central nervous system diseases.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- The SERPINI1 gene (protease inhibitor) is downregulated in brain tumors.
- The PDCD10 gene (programmed cell death) is mutated in cerebral cavernous malformation.
- These two genes are located adjacently on human chromosome 3q26.
Purpose of the Study:
- To investigate the regulatory mechanism of the bidirectional promoter between SERPINI1 and PDCD10.
- To identify transcription factors involved in the coordinated expression of these two genes.
- To explore the role of c-Myc and DNA methylation in regulating SERPINI1 and PDCD10 expression.
Main Methods:
- Analysis of the intergenic region between SERPINI1 and PDCD10.
- Identification of a minimal bidirectional promoter.
- Electrophoretic mobility shift assays (EMSA) to study transcription factor binding.
- Investigation of DNA methylation effects on transcription factor binding.
Main Results:
- A 175-bp GC-rich bidirectional promoter was identified in the intergenic region.
- The oncogenic c-Myc transcription factor binds to a non-canonical E-box (5'-CATGCG-3') within the promoter.
- Methylation at a specific cytosine within the E-box significantly inhibits c-Myc binding.
- c-Myc binding drives the expression of both SERPINI1 and PDCD10.
Conclusions:
- c-Myc plays a crucial role in the coordinated transcription of the PDCD10-SERPINI1 gene pair.
- DNA methylation of the E-box can modulate c-Myc binding and gene expression.
- These findings suggest c-Myc's involvement in the differential expression of these genes in central nervous system diseases like brain cancer.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
